$25.16
4.37% today
Nasdaq, Apr 03, 06:41 pm CET
ISIN
US68752L1008
Symbol
KIDS

OrthoPediatrics Corp. Target price 2025 - Analyst rating & recommendation

OrthoPediatrics Corp. Classifications & Recommendation:

Buy
83%
Hold
17%

OrthoPediatrics Corp. Price Target

Target Price $39.00
Price $26.31
Potential
Number of Estimates 6
6 Analysts have issued a price target OrthoPediatrics Corp. 2026 . The average OrthoPediatrics Corp. target price is $39.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 5 Analysts recommend OrthoPediatrics Corp. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the OrthoPediatrics Corp. stock has an average upside potential 2026 of . Most analysts recommend the OrthoPediatrics Corp. stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 204.73 238.74
37.65% 16.61%
EBITDA Margin -5.26% 6.63%
6.72% 226.15%
Net Margin -19.40% -12.99%
28.11% 33.05%

6 Analysts have issued a sales forecast OrthoPediatrics Corp. 2025 . The average OrthoPediatrics Corp. sales estimate is

$239m
Unlock
. This is
16.61% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$240m 17.33%
Unlock
, the lowest is
$238m 16.01%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $205m 37.65%
2025
$239m 16.61%
Unlock
2026
$279m 16.86%
Unlock
2027
$321m 15.23%
Unlock

5 Analysts have issued an OrthoPediatrics Corp. EBITDA forecast 2025. The average OrthoPediatrics Corp. EBITDA estimate is

$15.8m
Unlock
. This is
251.59% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$16.4m 257.39%
Unlock
, the lowest is
$14.8m 241.76%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-10.8m 28.40%
2025
$15.8m 247.08%
Unlock
2026
$26.4m 67.09%
Unlock
2027
$36.5m 38.13%
Unlock

EBITDA Margin

2024 -5.26% 6.72%
2025
6.63% 226.15%
Unlock
2026
9.48% 42.99%
Unlock
2027
11.36% 19.83%
Unlock

4 OrthoPediatrics Corp. Analysts have issued a net profit forecast 2025. The average OrthoPediatrics Corp. net profit estimate is

$-31.0m
Unlock
. This is
21.96% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-26.9m 32.33%
Unlock
, the lowest is
$-36.3m 8.54%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-39.7m 76.34%
2025
$-31.0m 21.96%
Unlock
2026
$-24.9m 19.71%
Unlock
2027
$-22.4m 10.16%
Unlock

Net Margin

2024 -19.40% 28.11%
2025
-12.99% 33.05%
Unlock
2026
-8.92% 31.33%
Unlock
2027
-6.96% 21.97%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.64 -1.28
76.34% 21.95%
P/E negative
EV/Sales 2.73

4 Analysts have issued a OrthoPediatrics Corp. forecast for earnings per share. The average OrthoPediatrics Corp. EPS is

$-1.28
Unlock
. This is
21.95% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.11 32.32%
Unlock
, the lowest is
$-1.50 8.54%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.64 76.34%
2025
$-1.28 21.95%
Unlock
2026
$-1.03 19.53%
Unlock
2027
$-0.92 10.68%
Unlock

P/E ratio

Current -16.07 49.02%
2025
-20.55 27.88%
Unlock
2026
-25.61 24.62%
Unlock
2027
-28.49 11.25%
Unlock

Based on analysts' sales estimates for 2025, the OrthoPediatrics Corp. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.19 24.41%
2025
2.73 14.27%
Unlock
2026
2.34 14.43%
Unlock
2027
2.03 13.22%
Unlock

P/S ratio

Current 3.12 32.40%
2025
2.68 14.24%
Unlock
2026
2.29 14.43%
Unlock
2027
1.99 13.22%
Unlock

Current OrthoPediatrics Corp. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citizens Capital Markets
Locked
Locked
Locked Mar 21 2025
Needham
Locked
Locked
Locked Mar 05 2025
Stifel
Locked
Locked
Locked Mar 05 2025
Needham
Locked
Locked
Locked Jan 14 2025
Truist Securities
Locked
Locked
Locked Dec 18 2024
Needham
Locked
Locked
Locked Nov 08 2024
Truist Securities
Locked
Locked
Locked Oct 14 2024
Analyst Rating Date
Locked
Citizens Capital Markets:
Locked
Locked
Mar 21 2025
Locked
Needham:
Locked
Locked
Mar 05 2025
Locked
Stifel:
Locked
Locked
Mar 05 2025
Locked
Needham:
Locked
Locked
Jan 14 2025
Locked
Truist Securities:
Locked
Locked
Dec 18 2024
Locked
Needham:
Locked
Locked
Nov 08 2024
Locked
Truist Securities:
Locked
Locked
Oct 14 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today